Erewhon

Los Angeles, CA

About Erewhon

Company overview

Erewhon is a luxury health-food supermarket chain founded in 1966 by Michio and Aveline Kushi, with its headquarters located in Los Angeles, California. Originally established in Boston as a small macrobiotic and natural foods producer, the brand was a pioneer in the organic food movement in the United States. The company's name is an anagram of "nowhere," derived from Samuel Butler's 1872 satirical novel Erewhon, which depicts a utopia where individuals are responsible for their own health. In 2011, Tony and Josephine Antoci acquired the business and transformed it from a singular health food store into an upscale, celebrity-favored grocery brand. The company has since expanded significantly, particularly following a 2019 investment from the private equity firm Stripes Group. In June 2021, Erewhon became a certified B Corporation, reflecting its commitment to social and environmental standards. Business/Product Breakdown Erewhon operates as an high-end grocery retailer specializing in organic, ethically sourced, and nutrient-rich products. The company maintains multiple physical locations across Los Angeles County and offers nationwide shipping for its curated collections. Its product offerings include a wide array of organic produce, specialty health foods, dietary supplements, and a robust selection of prepared items such as gourmet sandwiches and sushi. A signature component of the brand's retail experience is its tonic bar, which features viral celebrity-collaboration smoothies made with premium ingredients. Beyond food and beverages, the company sells private-label "Erewhon Essentials," including branded apparel, bags, and household items. The company emphasizes a community-centric model, utilizing store design and high-value product curation to position grocery shopping as a lifestyle and wellness experience.

Keywords

Revenue

Revenue

EBITDA

EBITDA

Valuation

Valuation
Income Statement
Line Item20242023202220212020
Revenues$380 MM$250 MM$90 MM$120 MM$65 MM
Gross Profit$190 MM$125 MM$45 MM$60 MM$32.50 MM
Net Income (Loss)$43 MM$25 MM$9 MM$12 MM$6.50 MM
Members Only
Unlock full access to financial data and insights
Balance Sheet
Line Item20242023202220212020
Total Assets$850 MM$720 MM$680 MM$650 MM$600 MM
Total Liabilities$450 MM$400 MM$380 MM$350 MM$320 MM
Total Equity$400 MM$320 MM$300 MM$300 MM$280 MM
Members Only
Unlock full access to financial data and insights

Ratios

Revenue / EBITDA
123 MM
Valuation / Revenue
123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

© 2026 PrivCo Holding Inc. All rights reserved.

No AI Training or Automated Data Extraction.

Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.